JPRN-UMIN000025062已完成未知
Pemetrexed monotherapy in chemo-naive elderly patients with advanced non-squamous non-small cell lung cancer. - Pemetrexed monotherapy in chemo-naive elderly patients with advanced non-squamous non-small cell lung cancer.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Superior vena cava syndrome 2. History of severe hypersensitivity to drugs 3. Uncontrolled pleural effusion, peritoneal effusion, and cardiac effusion 4. Severe infectious disease or severe uncontrolled complication 5. Interstitial lung disease or pulmonary fibrosis 6. Active malignancy of other organ
研究者
相似试验
已完成
2 期
A Phase 2 Study of Pemetrexed in Elderly Patients with Previously Untreated Non-Squamous Non-Small-Cell Lung CancerJPRN-UMIN000002468Kobe Lung Cancer Study Group45
已完成
不适用
Phase II trial of Pemetrexed for elderly advanced non-squamous non-small cell lung cancernon-sq NSCLCJPRN-UMIN000002452Kyoto Thoracic Oncology Research Group28
已完成
2 期
A Phase II Study of Pemetrexed in Elderly Patients with Previously Untreated Non-Squamous Non-Small-Cell Lung CancerElderly patients with previously untreated non-squamous non-small cell lung cancerJPRN-UMIN000003691ung Cancer Experts Network30
已完成
不适用
Carboplatin and pemetrexed in chemo-naive patients with advanced non-squamous non-small cell lung cancer.on-squamous non-small cell lung cancerJPRN-UMIN000025061Kurashiki Central Hospital90
进行中（未招募）
不适用
Pemetrexed monochemotherapy in patients with locally advanced or metastatic Non Small Cell Lung Cancer. A pilot study to define the best dosing schedule for a planned phase II randomized trial. - NDIIIB and IV non-small cell lung cancerMedDRA version: 9.1Level: LLTClassification code 10026532Term: Malignant neoplasm of thoraxEUCTR2006-001836-32-ITELI LILLY